Jacqueline U. Mcdonald

Potters Bar, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus.

Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus.

Journal: Vaccine
Published: December 16, 2024

Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.

Inno4Vac Workshop Report Part 2: RSV-Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK.

Journal: Influenza and other respiratory viruses
Published: September 02, 2024

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies.

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies.

Journal: Vaccines
Published: July 22, 2022

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.

Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.

Journal: Vaccines
Published: October 06, 2020

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.

Expansion of the 1st WHO international standard for antiserum to respiratory syncytial virus to include neutralisation titres against RSV subtype B: An international collaborative study.

Journal: Vaccine
Published: September 02, 2019

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study.

Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study.

Journal: Vaccine
Published: August 13, 2018

Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy.

Mouse Models of Influenza Infection with Circulating Strains to Test Seasonal Vaccine Efficacy.

Journal: Frontiers in immunology
Published: October 13, 2017

Airway T cells protect against RSV infection in the absence of antibody.

Airway T cells protect against RSV infection in the absence of antibody.

Journal: Mucosal immunology
Published: August 31, 2017

Inflammatory responses to influenza vaccination at the extremes of age.

Inflammatory responses to influenza vaccination at the extremes of age.

Journal: Immunology
Published: January 03, 2017

Airway T cells protect against RSV infection in the absence of antibody.

Airway T cells protect against RSV infection in the absence of antibody.

Journal: Mucosal immunology
Published: August 12, 2016

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.

Journal: Frontiers in immunology
Published: June 21, 2016

A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease.

A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease.

Journal: mSystems
Published: April 23, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026